Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Bussel

Showing results (31-40 of 487) with videos related to

Pageof 49
Sort By:
Seminars in Hematology|February 17, 2000
Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpuraJ B Bussel
Seminars in Thrombosis and Hemostasis|July 12, 2001
Alloimmune thrombocytopenia in the fetus and newbornJ B Bussel
Pediatric Annals|March 1, 1990
Thrombocytopenia in newborns, infants, and childrenJ B Bussel
The Journal of Supportive Oncology|June 7, 2007
Novel thrombopoietic agents: preliminary activity, potential benefitJames B Bussel
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Neonatal uses of intravenous immunoglobulinJ B Bussel
Seminars in Hematology|February 28, 2009
Therapeutic approaches to secondary immune thrombocytopenic purpuraJames B Bussel
British Journal of Haematology|October 24, 2018
AvatrombopagJames B Bussel
La Revue Du Praticien|January 1, 1981
[Means of control of muscular spasticity]B Bussel, A Picard
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|May 16, 2006
[Intrathecal baclofen. Twenty years later]B Bussel, D Bensmail
Journal of Pediatric Hematology/Oncology|March 1, 2000
Hematologic toxicity of sodium valproateS Acharya, J B Bussel
Pageof 49

Showing results (31-40 of 487) with videos related to

Sort By:
Pageof 49
Seminars in Hematology|February 17, 2000
Splenectomy-sparing strategies for the treatment and long-term maintenance of chronic idiopathic (immune) thrombocytopenic purpuraJ B Bussel
Seminars in Thrombosis and Hemostasis|July 12, 2001
Alloimmune thrombocytopenia in the fetus and newbornJ B Bussel
Pediatric Annals|March 1, 1990
Thrombocytopenia in newborns, infants, and childrenJ B Bussel
The Journal of Supportive Oncology|June 7, 2007
Novel thrombopoietic agents: preliminary activity, potential benefitJames B Bussel
The American Journal of Pediatric Hematology/Oncology|January 1, 1990
Neonatal uses of intravenous immunoglobulinJ B Bussel
Seminars in Hematology|February 28, 2009
Therapeutic approaches to secondary immune thrombocytopenic purpuraJames B Bussel
British Journal of Haematology|October 24, 2018
AvatrombopagJames B Bussel
La Revue Du Praticien|January 1, 1981
[Means of control of muscular spasticity]B Bussel, A Picard
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|May 16, 2006
[Intrathecal baclofen. Twenty years later]B Bussel, D Bensmail
Journal of Pediatric Hematology/Oncology|March 1, 2000
Hematologic toxicity of sodium valproateS Acharya, J B Bussel
Pageof 49